Silica nanoparticles sensitize human multiple myeloma cells to snake (Walterinnesia aegyptia) venom-induced apoptosis and growth arrest

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Sayed, Douaa ^a   Al Sadoon, Mohamed K ^b   Badr, Gamal ^c,d  

^a Assiut University Faculty of Medicine   (Egypt)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d Assiut University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL EFFECTS; BLOOD CANCER; CELL CYCLE; CHEMORESISTANCE; CHEMOTHERAPEUTIC TREATMENTS; FLOW CYTOMETRY ANALYSIS; GROWTH ARREST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INCURABLE DISEASE; MULTIPLE MYELOMA; PROLIFERATION AND APOPTOSIS; PROPIDIUM IODIDE; PROSTATE CANCER CELLS; SILICA NANOPARTICLES; STAINING METHOD;

CELL PROLIFERATION; DISEASES; DRUG PRODUCTS;

CELL DEATH;

CASPASE 3; CASPASE 8; CASPASE 9; HYDROPEROXIDE; NANOPARTICLE; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; SNAKE VENOM; CASPASE; HYDROGEN PEROXIDE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; SENSITIZATION; SNAKE; WALTERINNESIA EGYPTIA; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; ELAPIDAE; ENZYMOLOGY; METABOLISM; PARTICLE SIZE; PATHOLOGY; TEMPERATURE; TIME; ULTRASTRUCTURE;

WALTERINNESIA AEGYPTIA;

ANIMALS; APOPTOSIS; CASPASES; CELL PROLIFERATION; CELL SURVIVAL; ELAPID VENOMS; ELAPIDAE; HUMANS; HYDROGEN PEROXIDE; MULTIPLE MYELOMA; NANOPARTICLES; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; SILICON DIOXIDE; TEMPERATURE; TIME FACTORS;

MLCS; MLOWN;

EID: 84872127072     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/386286     Document Type: Article

References (26)

1. Gupta D., Hideshima T., Anderson K. C., Novel biologically based therapeutic strategies in myeloma. Reviews in Clinical and Experimental Hematology 2002 6 3 301 324 2-s2.0-0036760132 10.1046/j.1468-0734.2002.00082.x (Pubitemid 35408175)
2. Zhao M., Ma J., Zhu H.-Y., Apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90. Molecular Cancer 2011 10, article 104
3. Markland F. S., Shieh K., Zhou Q., Golubkov V., Sherwin R. P., Richters V., Sposto R., A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model. Haemostasis 2001 31 3-6 183 191 2-s2.0-0035742117 (Pubitemid 34702051)
4. Badr G., Al-Sadoon M. K., El-Toni A. M., Daghestani M., Walterinnesia aegyptia venom combined with silica nanoparticles enhances the functioning of normal lymphocytes through PI3K/AKT, NF B and ERK signaling. Lipids in Health and Disease 2012 11, article 27
5. Son D. J., Park M. H., Chae S. J., Moon S. O., Lee J. W., Song H. S., Moon D. C., Kang S. S., Kwon Y. E., Hong J. T., Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor B. Molecular Cancer Therapeutics 2007 6 2 675 683 2-s2.0-33847368594 10.1158/1535-7163.MCT-06-0328 (Pubitemid 46332468)
6. Barratt G., Colloidal drug carriers: achievements and perspectives. Cellular and Molecular Life Sciences 2003 60 1 21 37 2-s2.0-0037275061 10.1007/s000180300002 (Pubitemid 36223115)
7. Al-Sadoon M. K., Abdel-Maksoud M. A., Rabah D. M., Badr G. Induction of apoptosis and growth arrest in human breast carcinoma cells by a snake (Walterinnesia aegyptia) venom combined with silica nanoparticles: crosstalk between Bcl2 and caspase 3. Cellular Physiology and Biochemistry 2012 30 3 653 665
8. Park M. H., Jo M. R., Won D., Song H. S., Han S. B., Song M. J., Hong J. T., Snake venom toxin from Vipera lebetina turanica induces apoptosis in colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expression. BMC Cancer 2012 12 12, article 228
9. Song J. K., Jo M. R., Park M. H., Cell growth inhibition and induction of apoptosis by snake venom toxin in ovarian cancer cell via inactivation of nuclear factor B and signal transducer and activator of transcription 3. Archives of Pharmacal Research 2012 35 5 867 876
10. Bruckheimer E. M., Kyprianou N., Apoptosis in prostate carcinogenesis: a growth regulator and a therapeutic target. Cell and Tissue Research 2000 301 1 153 162 2-s2.0-0033942505 (Pubitemid 30459862)
11. Nishihori T., Alsina M., Advances in the autologous and allogeneic transplantation strategies for multiple myeloma. Cancer Control 2011 18 258 267
12. Ishii Y., Hsiao H. H., Sashida G., Ito Y., Miyazawa K., Kodama A., Ohyashiki J. H., Ohyashiki K., Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome. Cancer Genetics and Cytogenetics 2006 167 2 131 137 2-s2.0-33646843058 10.1016/j.cancergencyto.2006. 01.002 (Pubitemid 43776951)
13. Badr G., Lefevre E. A., Mohany M., Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis. PLoS ONE 2011 6 9 e23741
14. Kolluru L. P., Rizvi S. A., D'Souza M., D'Souza M. J., Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting. Journal of Drug Targeting. In press
15. Hillaireau H., Couvreur P., Nanocarriers' entry into the cell: relevance to drug delivery. Cellular and Molecular Life Sciences 2009 66 17 2873 2896 2-s2.0-68949208465 10.1007/s00018-009-0053-z
16. Wang J., Sui M., Fan W., Nanoparticles for tumor targeted therapies and their pharmacokinetics. Current Drug Metabolism 2010 11 2 129 141 2-s2.0-77950840680 10.2174/138920010791110827
17. Haque F., Shu D., Shu Y., Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today 2012 7 245 257
18. Nam H. Y., Kwon S. M., Chung H., Lee S. Y., Kwon S. H., Jeon H., Kim Y., Park J. H., Kim J., Her S., Oh Y. K., Kwon I. C., Kim K., Jeong S. Y., Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. Journal of Controlled Release 2009 135 3 259 267 2-s2.0-63649092083 10.1016/j.jconrel.2009.01.018
19. Koo H., Huh M. S., Sun I. C., In vivo targeted delivery of nanoparticles for theranosis. Accounts of Chemical Research 2011 44 1018 1028
20. Lim S. M., Kim T. H., Jiang H. H., Park C. W., Lee S., Chen X., Lee K. C., Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles. Biomaterials 2011 32 13 3538 3546 2-s2.0-79952007696 10.1016/j.biomaterials.2011.01.054
21. Koppolu B., Bhavsar Z., Wadajkar A. S., Temperature-sensitive polymer-coated magnetic nanoparticles as a potential drug delivery system for targeted therapy of thyroid cancer. Journal of Biomedical Nanotechnology 2012 8 983 990
22. Zeng X., Zhang Y., Nyström A. M., Endocytic uptake and intracellular trafficking of bis-MPA based hyperbranched copolymer micelles in breast cancer cells. Biomacromolecules 2012 13 11 3814 3822
23. Lühmann T., Rimann M., Bittermann A. G., Hall H., Cellular uptake and intracellular pathways of PLL-g-PEG-DNA nanoparticles. Bioconjugate Chemistry 2008 19 9 1907 1916 2-s2.0-52249118360 10.1021/bc800206r
24. Ahmad J., Ahamed M., Akhtar M. J., Alrokayan S. A., Siddiqui M. A., Musarrat J., Al-Khedhairy A. A., Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2. Toxicology and Applied Pharmacology 2012 259 2 160 168
25. Kozako T., Arima N., Yoshimitsu M., Honda S. I., Soeda S., Liposomes and nanotechnology in drug development: focus on oncotargets. International Journal of Nanomedicine 2012 7 4943 4951
26. Dos Santos T., Varela J., Lynch I., Salvati A., Dawson K. A., Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS ONE 2011 6 e24438